Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kimia Farma Tbk (KAEF) vs Reksa Dana Premier ETF Indonesia Sovereign Bonds (XISB) Price & Performance

Kimia Farma TbkTrade
Reksa Dana Premier ETF Indonesia Sovereign BondsTrade

Price performance (Past 24H)

Key statistics

Kimia Farma Tbk vs Reksa Dana Premier ETF Indonesia Sovereign Bonds — how do they compare? Kimia Farma Tbk trades at Rp454 (market cap 2.53T, 524K 24h volume), while Reksa Dana Premier ETF Indonesia Sovereign Bonds trades at Rp533 (market cap 32.19B, 800 24h volume). The key difference: Kimia Farma Tbk is far larger — about 78.6× Reksa Dana Premier ETF Indonesia Sovereign Bonds's market cap, and Kimia Farma Tbk is more actively traded (524K versus 800). Which is the better fit depends on your goals.

KAEFXISB
Market Cap
2.53T32.19B
Volume
524K800
Lot
5.24K8
Turnover
236.25M426.4K
Average Price
450.87533
Value
236.25M426.4K
Indicative Equilibrium Price
454
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KAEF
View details

About Kimia Farma Tbk

PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.

Read more on KAEF

About Reksa Dana Premier ETF Indonesia Sovereign Bonds

Read more on XISB